On Monday, IGC Pharma Inc (AMEX: IGC) was -4.29% drop from the session before settling in for the closing price of $0.37. A 52-week range for IGC has been $0.25 – $0.91.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 4.59% over the last five years. When this article was written, the company’s average yearly earnings per share was at 40.91%. With a float of $52.67 million, this company’s outstanding shares have now reached $76.64 million.
The firm has a total of 67 workers. Let’s measure their productivity. In terms of profitability, gross margin is 44.38%, operating margin of -788.17%, and the pretax margin is -1062.47%.
IGC Pharma Inc (IGC) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward IGC Pharma Inc stocks. The insider ownership of IGC Pharma Inc is 32.00%, while institutional ownership is 3.62%. The most recent insider transaction that took place on Sep 25 ’24, was worth 200,000. In this transaction Director of this company bought 588,235 shares at a rate of $0.34, taking the stock ownership to the 942,402 shares. Before that another transaction happened on Aug 12 ’24, when Company’s Director proposed sale 200,000 for $0.39, making the entire transaction worth $78,200.
IGC Pharma Inc (IGC) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.05 earnings per share (EPS) during the time that was less than consensus figure (set at -0.04) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.91% per share during the next fiscal year.
IGC Pharma Inc (AMEX: IGC) Trading Performance Indicators
You can see what IGC Pharma Inc (IGC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 23.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.12 in one year’s time.
Technical Analysis of IGC Pharma Inc (IGC)
Analysing the last 5-days average volume posted by the [IGC Pharma Inc, IGC], we can find that recorded value of 0.6 million was better than the volume posted last year of 0.51 million. As of the previous 9 days, the stock’s Stochastic %D was 51.35%. Additionally, its Average True Range was 0.03.
During the past 100 days, IGC Pharma Inc’s (IGC) raw stochastic average was set at 16.07%, which indicates a significant decrease from 36.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.24% in the past 14 days, which was lower than the 57.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3744, while its 200-day Moving Average is $0.4171. Now, the first resistance to watch is $0.3804. This is followed by the second major resistance level at $0.4038. The third major resistance level sits at $0.4187. If the price goes on to break the first support level at $0.3421, it is likely to go to the next support level at $0.3272. Now, if the price goes above the second support level, the third support stands at $0.3038.
IGC Pharma Inc (AMEX: IGC) Key Stats
There are 77,449K outstanding shares of the company, which has a market capitalization of 27.58 million. As of now, sales total 1,350 K while income totals -13,000 K. Its latest quarter income was 410 K while its last quarter net income were -1,720 K.
